SCHEMBL22858074

SCHEMBL22858074

CC(C)(C)OC(=O)Nc1cnn2cc(Cl)nc2c1C(=O)O

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ P2RX7 Q99572 1/20 0.39
▸ GSK3B P49841 1/20 0.38
▸ DYRK1A Q13627 1/20 0.38
▸ BRD9 Q9H8M2 1/20 0.36
▸ MAPKAPK2 P49137 3/20 0.35
▸ HDAC3 O15379 1/20 0.35
▸ HDAC8 Q9BY41 1/20 0.35
▸ NCOR2 Q9Y618 1/20 0.35
▸ BRD4 O60885 1/20 0.35
▸ SCD O00767 1/20 0.34
▸ P2RX3 P56373 2/20 0.34
▸ ATR Q13535 1/20 0.34
▸ IDO1 P14902 2/20 0.34
▸ RORC P51449 1/20 0.34
▸ RXFP1 Q9HBX9 1/20 0.33
▸ METAP1 P53582 1/20 0.33
▸ IRAK4 Q9NWZ3 1/20 0.33
▸ ADORA3 P0DMS8 1/20 0.32
▸ ADORA2B P29275 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22858075 0.87 GSK3B (0.36) P2RX7GSK3BDYRK1ABRD9MAPKAPK2
SCHEMBL22858190 0.84 P2RX7 (0.37) P2RX7GSK3BDYRK1ABRD9MAPKAPK2
SCHEMBL24424754 0.77 NTRK1 (0.42) P2RX7GSK3BDYRK1ABRD9MAPKAPK2
SCHEMBL22858199 0.72 KDM4E (0.36) —
SCHEMBL28718451 0.72 IRAK4 (0.37) GSK3BDYRK1ABRD9HDAC3HDAC8
SCHEMBL22843008 0.72 ATR (0.41) GSK3BDYRK1ABRD9ATRIDO1
SCHEMBL29143532 0.71 ATR (0.42) P2RX7BRD9MAPKAPK2BRD4P2RX3
SCHEMBL22843003 0.71 IRAK4 (0.40) GSK3BDYRK1ABRD9ATRIDO1
SCHEMBL22858072 0.70 CSNK2A1 (0.32) P2RX3ATRIRAK4
SCHEMBL1058517 0.70 ALDH1A1 (0.44) P2RX7BRD9BRD4ATR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021000855-A1 MALT1 INHIBITORS AND USES THEREOF QILU REGOR THERAPEUTICS INC. (CN) 2021-01-07 — — WO disclosed
Send feedback